Brind.

Morgan Stanley increased its stake in Corcept Therapeutics, and Norges Bank also bought a new stake in the company.

1 report, 1 independent Updated Jul 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Corcept Therapeutics Morgan Stanley Norges Bank

Keep exploring

The entities involved

Corcept Therapeutics
American pharmaceutical company

Nothing else this week.
Morgan Stanley
U.S. investment bank
- Morgan Stanley downgraded Coinbase stock rating, citing potential earnings impact from the Binance hack.15:27
- ConocoPhillips filed disclosures with the SEC, while Morgan Stanley boosted its price target and Freedom Capital upgraded its rating.15:27
Norges Bank
central bank of Norway
- Norges Bank monitors unemployment data from the Norwegian Labour and Welfare Administration, and both Norges Bank and Danske Bank influence krone valuation.10:51
- Merck KGaA stock saw activity as an EVP sold shares, while Mirae Asset increased its stake, alongside Norges Bank's previous acquisition.Sun 13:04

Related events

Corcept Therapeutics and Halozyme Therapeutics are identified as top holdings in specific U.S. small-cap ETFs.Oct 15

Coverage

Newest first; wire copies grouped

Jul 24themarketsdaily.com